A Randomized Trial of LOVAZA in Pediatric Sickle Cell Disease (SCD)

Clinical trial NCT01202812 · UNKNOWN

Trial details

NCT number: NCT01202812
Sponsor: Thomas Jefferson University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease HEMOGLOBIN SS Hemoglobin S Beta-0 Thalassemia Inflammation Quality of Life

Start date: 2010-10-01
Primary completion: 2012-03-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.